Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Ondansetron × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 3 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Nausea 1

Interventions

Saline Solution 6 Sodium Chloride 5 Fentanyl 5 Pregabalin 4 Ketamine 4 Dexamethasone 4 Bevacizumab 4 Tranexamic Acid 3 Photochemotherapy 3 Metformin 3 Letrozole 3 Goserelin 3 Docetaxel 3 Cyclophosphamide 3 Capecitabine 3 ulipristal acetate 2 sodium glycididazole 2 nilotinib 2 liposomal doxorubicin 2 human papillomavirus vaccine, L1 type 16, 18 2 flurbiprofen axetil 2 fludarabine 2 fluciclovine F-18 2 epoetin beta 2 dexamethasone 21-phosphate 2 aldesleukin 2 Trastuzumab 2 Surveys and Questionnaires 2 Sorafenib 2 Solutions 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00588835 2020-11-30

ACE

Radboud University Medical Center

Phase 4 Terminated

Nausea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡